Skip to main content

Telomir Pharmaceuticals, Inc.

corporate_fare Company Profile

Telomir Pharmaceuticals, Inc.

Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on reversing biological aging and degenerative diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Progeria, Wilson's disease, and age-related macular degeneration (amd), as well as type 2 diabetes, cancer, and Alzheimer's disease. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.

Exchange: NASDAQSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed TELO - Latest Insights

TELO
Apr 24, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
8
TELO
Apr 24, 2026, 9:00 AM EDT
Source: Access Newswire
Importance Score:
8
TELO
Mar 31, 2026, 9:15 AM EDT
Filing Type: 8-K
Importance Score:
7
TELO
Mar 31, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
8
TELO
Mar 27, 2026, 5:03 PM EDT
Source: Wiseek News
Importance Score:
8
TELO
Mar 27, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
TELO
Mar 17, 2026, 5:28 PM EDT
Filing Type: 10-K
Importance Score:
9
TELO
Feb 19, 2026, 5:12 PM EST
Filing Type: DEFA14A
Importance Score:
9
TELO
Feb 17, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
8
TELO
Feb 05, 2026, 7:30 AM EST
Filing Type: 8-K
Importance Score:
7
TELO
Feb 04, 2026, 7:03 PM EST
Filing Type: PRER14A
Importance Score:
9
TELO
Jan 23, 2026, 5:04 PM EST
Filing Type: PRER14A
Importance Score:
9
TELO
Jan 09, 2026, 7:50 PM EST
Filing Type: 8-K
Importance Score:
9
TELO
Jan 05, 2026, 8:01 AM EST
Filing Type: 8-K
Importance Score:
7